Lectin-glycan interaction network-based identification of host receptors of microbial pathogenic adhesins

mBio

Volumn 7, Issue 4, 2016, Pages

  Ielasi, Francesco S ^a,d   Alioscha Perez, Mitchel ^a   Donohue, Dagmara ^a   Claes, Sandra ^b   Sahli, Hichem ^a,c   Schols, Dominique ^b   Willaert, Ronnie G ^a  

^a VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

^b REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

^c IMEC   (Belgium)

^d INSTITUT PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADHESIN; ALS1P ADHESIN; ALS3P ADHESIN; EPA1 ADHESIN; EPA6 ADHESIN; EPA7 ADHESIN; GLYCAN; LECTIN; UNCLASSIFIED DRUG; CELL SURFACE RECEPTOR; FUNGAL PROTEIN; POLYSACCHARIDE; PROTEIN BINDING;

ARTICLE; BACTERIAL VIRULENCE; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDIASIS; ENZYME ACTIVITY; ESCHERICHIA COLI; FUNGAL VIRULENCE; HOST PATHOGEN INTERACTION; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN PROTEIN INTERACTION; CELL LINE; METABOLISM;

ADHESINS, BACTERIAL; CELL LINE; FUNGAL PROTEINS; HUMANS; LECTINS; POLYSACCHARIDES; PROTEIN BINDING; RECEPTORS, CELL SURFACE;

EID: 84986540260     PISSN: 21612129     EISSN: 21507511     Source Type: Journal    
DOI: 10.1128/mBio.00584-16     Document Type: Article

References (93)

1. Reitsma S, Slaaf DW, Vink H, Zandvoort MAMJ, Oude Egbrink MGA. 2007. The endothelial glycocalyx: composition, functions, and visualization. Pflugers Arch 454:345-359. http://dx.doi.org/10.1007/s00424-007-0212-8.
2. Critchley IA, Douglas LJ. 1987. Role of glycosides as epithelial cell receptors for Candida albicans. J Gen Microbiol 133:637-643. http://dx.doi.org/10.1099/00221287-133-3-637.
3. Vardar-Unlü G, McSharry C, Douglas LJ. 1998. Fucose-specific adhesins on germ tubes of Candida albicans. FEMS Immunol Med Microbiol 20: 55-67. http://dx.doi.org/10.1016/S0928-8244(97)00107-7.
4. Cummings RD. 2009. The repertoire of glycan determinants in the human glycome. Mol Biosyst 5:1087-1104. http://dx.doi.org/10.1039/b907931a.
5. Blixt O, Head S, Mondala T, Scanlan C, Huflejt ME, Alvarez R, Bryan MC, Fazio F, Calarese D, Stevens J, Razi N, Stevens DJ, Skehel JJ, van Die I, Burton DR, Wilson IA, Cummings R, Bovin N, Wong C-H, Paulson JC. 2004. Printed covalent glycan array for ligand profiling of diverse glycan binding proteins. Proc Natl Acad Sci U S A 101: 17033-17038. http://dx.doi.org/10.1073/pnas.0407902101.
6. Ulett GC, Totsika M, Schaale K, Carey AJ, Sweet MJ, Schembri MA. 2013. Uropathogenic Escherichia coli virulence and innate immune responses during urinary tract infection. Curr Opin Microbiol 16:100-107. http://dx.doi.org/10.1016/j.mib.2013.01.005.
7. Hahn E, Wild P, Hermanns U, Sebbel P, Glockshuber R, Häner M, Taschner N, Burkhard P, Aebi U, Müller SA. 2002. Exploring the 3D molecular architecture of Escherichia coli type 1 pili. J Mol Biol 323: 845-857. http://dx.doi.org/10.1016/S0022-2836(02)01005-7.
8. Westerlund-Wikström B, Korhonen TK. 2005. Molecular structure of adhesin domains in Escherichia coli fimbriae. Int J Med Microbiol 295: 479-486. http://dx.doi.org/10.1016/j.ijmm.2005.06.010.
9. Choudhury D, Thompson A, Stojanoff V, Langermann S, Pinkner J, Hultgren SJ, Knight SD. 1999. X-ray structure of the FimC-FimH chaperone-adhesin complex from uropathogenic Escherichia coli. Science 285:1061-1066. http://dx.doi.org/10.1126/science.285.5430.1061.
10. Bouckaert J, Berglund J, Schembri M, De Genst E, Cools L, Wuhrer M, Hung C-S, Pinkner J, Slättegård R, Zavialov A, Choudhury D, Langermann S, Hultgren SJ, Wyns L, Klemm P, Oscarson S, Knight SD, De Greve H. 2005. Receptor binding studies disclose a novel class of highaffinity inhibitors of the Escherichia coli FimH adhesin. Mol Microbiol 55:441-455. http://dx.doi.org/10.1111/j.1365-2958.2004.04415.x.
11. Bouckaert J, Mackenzie J, de Paz JL, Chipwaza B, Choudhury D, Zavialov A, Mannerstedt K, Anderson J, Piérard D, Wyns L, Seeberger PH, Oscarson S, De Greve H, Knight SD. 2006. The affinity of the FimH fimbrial adhesin is receptor-driven and quasi-independent of Escherichia coli pathotypes. Mol Microbiol 61:1556-1568. http://dx.doi.org/10.1111/j.1365-2958.2006.05352.x.
12. Wu XR, Sun TT, Medina JJ. 1996. In vitro binding of type 1-fimbriated Escherichia coli to uroplakins Ia and Ib: relation to urinary tract infections. Proc Natl Acad Sci U S A 93:9630-9635. http://dx.doi.org/10.1073/pnas.93.18.9630.
13. Mulvey MA, Lopez-Boado YS, Wilson CL, Roth R, Parks WC, Heuser J, Hultgren SJ. 1998. Induction and evasion of host defenses by type 1-piliated uropathogenic Escherichia coli. Science 282:1494-1497. http://dx.doi.org/10.1126/science.282.5393.1494.
14. Mayer FL, Wilson D, Hube B. 2013. Candida albicans pathogenicity mechanisms. Virulence 4:119-128. http://dx.doi.org/10.4161/viru.22913.
15. Silva S, Negri M, Henriques M, Oliveira R, Williams DW, Azeredo J. 2012. Candida glabrata, Candida parapsilosis and Candida tropicalis: biology, epidemiology, pathogenicity and antifungal resistance. FEMS Microbiol Rev 36:288-305. http://dx.doi.org/10.1111/j.1574-6976.2011.00278.x.
16. Hoyer LL, Green CB, Oh S-H, Zhao X. 2008. Discovering the secrets of the Candida albicans agglutinin-like sequence (ALS) gene family—a sticky pursuit. Med Mycol 46:1-15. http://dx.doi.org/10.1080/13693780701435317.
17. Loza L, Fu Y, Ibrahim AS, Sheppard DC, Filler SG, Edwards JE. 2004. Functional analysis of the Candida albicans ALS1 gene product. Yeast 21: 473-482. http://dx.doi.org/10.1002/yea.1111.
18. Sheppard DC, Yeaman MR, Welch WH, Phan QT, Fu Y, Ibrahim AS, Filler SG, Zhang M, Waring AJ, Edwards JE. 2004. Functional and structural diversity in the Als protein family of Candida albicans. J Biol Chem 279:30480-30489. http://dx.doi.org/10.1074/jbc.M401929200.
19. Klotz SA, Gaur NK, Lake DF, Chan V, Rauceo J, Lipke PN. 2004. Degenerate peptide recognition by Candida albicans adhesins Als5p and Als1p. Infect Immun 72:2029-2034. http://dx.doi.org/10.1128/IAI.72.4.2029-2034.2004.
20. Argimón S, Wishart JA, Leng R, Macaskill S, Mavor A, Alexandris T, Nicholls S, Knight AW, Enjalbert B, Walmsley R, Odds FC, Gow NA, Brown AJ. 2007. Developmental regulation of an adhesin gene during cellular morphogenesis in the fungal pathogen Candida albicans. Eukaryot Cell 6:682-692. http://dx.doi.org/10.1128/EC.00340-06.
21. Liu Y, Filler SG. 2011. Candida albicans Als3, a multifunctional adhesin and invasin. Eukaryot Cell 10:168-173. http://dx.doi.org/10.1128/EC.00279-10.
22. Donohue DS, Ielasi FS, Goossens KV, Willaert RG. 2011. The N-terminal part of Als1 protein from Candida albicans specifically binds fucose-containing glycans. Mol Microbiol 80:1667-1679. http://dx.doi.org/10.1111/j.1365-2958.2011.07676.x.
23. Cormack BP, Ghori N, Falkow S. 1999. An adhesin of the yeast pathogen Candida glabrata mediating adherence to human epithelial cells. Science 285:578-582. http://dx.doi.org/10.1126/science.285.5427.578.
24. Domergue R, Castaño I, De Las Peñas A, Zupancic M, Lockatell V, Hebel JR, Johnson D, Cormack BP. 2005. Nicotinic acid limitation regulates silencing of Candida adhesins during UTI. Science 308:866-870. http://dx.doi.org/10.1126/science.1108640.
25. Zupancic ML, Frieman M, Smith D, Alvarez RA, Cummings RD, Cormack BP. 2008. Glycan microarray analysis of Candida glabrata adhesin ligand specificity. Mol Microbiol 68:547-559. http://dx.doi.org/10.1111/j.1365-2958.2008.06184.x.
26. Rigden DJ, Mello LV, Galperin MY. 2004. The PA14 domain, a conserved all-beta domain in bacterial toxins, enzymes, adhesins and signaling molecules. Trends Biochem Sci 29:335-339. http://dx.doi.org/10.1016/j.tibs.2004.05.002.
27. Ielasi FS, Decanniere K, Willaert RG. 2012. The epithelial adhesin 1 (Epa1p) from the human-pathogenic yeast Candida glabrata: structural and functional study of the carbohydrate-binding domain. Acta Crystallogr D Biol Crystallogr 68:210-217. http://dx.doi.org/10.1107/S0907444911054898.
28. Maestre-Reyna M, Diderrich R, Veelders MS, Eulenburg G, Kalugin V, Brückner S, Keller P, Rupp S, Mösch H-U, Essen L-O. 2012. Structural basis for promiscuity and specificity during Candida glabrata invasion of host epithelia. Proc Natl Acad Sci U S A 109:16864-16869. http://dx.doi.org/10.1073/pnas.1207653109.
29. Ielasi FS, Verhaeghe T, Desmet T, Willaert RG. 2014. Engineering the carbohydrate-binding site of Epa1p from Candida glabrata: generation of adhesin mutants with different carbohydrate specificity. Glycobiology 24: 1312-1322. http://dx.doi.org/10.1093/glycob/cwu075.
30. Balzarini J. 2005. Targeting the glycans of gp120: a novel approach aimed at the Achilles heel of HIV. Lancet Infect Dis 5:726-731. http://dx.doi.org/10.1016/S1473-3099(05)70271-1.
31. Wei X, Decker JM, Wang S, Hui H, Kappes JC, Wu X, Salazar-Gonzalez JF, Salazar MG, Kilby JM, Saag MS, Komarova NL, Nowak MA, Hahn BH, Kwong PD, Shaw GM. 2003. Antibody neutralization and escape by HIV-1. Nature 422:307-312. http://dx.doi.org/10.1038/nature01470.
32. Balzarini J. 2007. Targeting the glycans of glycoproteins: a novel paradigm for antiviral therapy. Nat Rev Microbiol 5:583-597. http://dx.doi.org/10.1038/nrmicro1707.
33. Scanlan CN, Offer J, Zitzmann N, Dwek RA. 2007. Exploiting the defensive sugars of HIV-1 for drug and vaccine design. Nature 446: 1038-1045. http://dx.doi.org/10.1038/nature05818.
34. Huskens D, Schols D. 2012. Algal lectins as potential HIV microbicide candidates. Mar Drugs 10:1476-1497. http://dx.doi.org/10.3390/md10071476.
35. Koharudin LM, Gronenborn AM. 2014. Antiviral lectins as potential HIV microbicides. Curr Opin Virol 7:95-100. http://dx.doi.org/10.1016/j.coviro.2014.05.006.
36. Akkouh O, Ng TB, Singh SS, Yin C, Dan X, Chan YS, Pan W, Cheung RC. 2015. Lectins with anti-HIV activity: a review. Molecules 20:648-668. http://dx.doi.org/10.3390/molecules20010648.
37. Dey B, Lerner DL, Lusso P, Boyd MR, Elder JH, Berger EA. 2000. Multiple antiviral activities of cyanovirin-N: blocking of human immunodeficiency virus type 1 gp120 interaction with CD4 and coreceptor and inhibition of diverse enveloped viruses. J Virol 74:4562-4569. http://dx.doi.org/10.1128/JVI.74.10.4562-4569.2000.
38. O’Keefe BR, Smee DF, Turpin JA, Saucedo CJ, Gustafson KR, Mori T, Blakeslee D, Buckheit R, Boyd MR. 2003. Potent anti-influenza activity of cyanovirin-N and interactions with viral hemagglutinin. Antimicrob Agents Chemother 47:2518-2525. http://dx.doi.org/10.1128/AAC.47.8.2518-2525.2003.
39. Barrientos LG, Lasala F, Otero JR, Sanchez A, Delgado R. 2004. In vitro evaluation of cyanovirin-N antiviral activity, by use of lentiviral vectors pseudotyped with filovirus envelope glycoproteins. J Infect Dis 189: 1440-1443. http://dx.doi.org/10.1086/382658.
40. Vigerust DJ, Shepherd VL. 2007. Virus glycosylation: role in virulence and immune interactions. Trends Microbiol 15:211-218. http://dx.doi.org/10.1016/j.tim.2007.03.003.
41. Keyaerts E, Vijgen L, Pannecouque C, Van Damme E, Peumans W, Egberink H, Balzarini J, Van Ranst M. 2007. Plant lectins are potent inhibitors of coronaviruses by interfering with two targets in the viral replication cycle. Antiviral Res 75:179-187. http://dx.doi.org/10.1016/j.antiviral.2007.03.003.
42. Alen MM, Kaptein SJ, De Burghgraeve T, Balzarini J, Neyts J, Schols D. 2009. Antiviral activity of carbohydrate-binding agents and the role of DC-SIGN in dengue virus infection. Virology 387:67-75. http://dx.doi.org/10.1016/j.virol.2009.01.043.
43. Sato Y, Morimoto K, Hirayama M, Hori K. 2011. High mannose-specific lectin (KAA-2) from the red alga Kappaphycus alvarezii potently inhibits influenza virus infection in a strain-independent manner. Biochem Biophys Res Commun 405:291-296. http://dx.doi.org/10.1016/j.bbrc.2011.01.031.
44. Kachko A, Loesgen S, Shahzad-Ul-Hussan S, Tan W, Zubkova I, Takeda K, Wells F, Rubin S, Bewley CA, Major ME. 2013. Inhibition of hepatitis C virus by the cyanobacterial protein Microcystis viridis lectin: mechanistic differences between the high-mannose specific lectins MVL, CV-N, and GNA. Mol Pharm 10:4590-4602. http://dx.doi.org/10.1021/mp400399b.
45. Garrison AR, Giomarelli BG, Lear-Rooney CM, Saucedo CJ, Yellayi S, Krumpe LR, Rose M, Paragas J, Bray M, Olinger GG, McMahon JB, Huggins J, O’Keefe BR. 2014. The cyanobacterial lectin scytovirin displays potent in vitro and in vivo activity against Zaire Ebola virus. Antiviral Res 112:1-7. http://dx.doi.org/10.1016/j.antiviral.2014.09.012.
46. Cooper CA, Harrison MJ, Wilkins MR, Packer NH. 2001. GlycoSuiteDB: a new curated relational database of glycoprotein glycan structures and their biological sources. Nucleic Acids Res 29:332-335. http://dx.doi.org/10.1093/nar/29.1.332.
47. Campbell MP, Peterson R, Mariethoz J, Gasteiger E, Akune Y, Aoki-Kinoshita KF, Lisacek F, Packer NH. 2014. UniCarbKB: building a knowledge platform for glycoproteomics. Nucleic Acids Res 42: D215-D221. http://dx.doi.org/10.1093/nar/gkt1128.
48. Iván G, Grolmusz V. 2011. When the web meets the cell: using personalized PageRank for analyzing protein interaction networks. Bioinformatics 27:405-407. http://dx.doi.org/10.1093/bioinformatics/btq680.
49. Hu Y. 2005. Efficient, high-quality force-directed graph drawing. Math J 10:37.
50. Yakovenko O, Sharma S, Forero M, Tchesnokova V, Aprikian P, Kidd B, Mach A, Vogel V, Sokurenko E, Thomas WE. 2008. FimH forms catch bonds that are enhanced by mechanical force due to allosteric regulation. J Biol Chem 283:11596-11605. http://dx.doi.org/10.1074/jbc.M707815200.
51. Pak J, Pu Y, Zhang ZT, Hasty DL, Wu XR. 2001. Tamm-Horsfall protein binds to type 1 fimbriated Escherichia coli and prevents E. coli from bind-ing to uroplakin Ia and Ib receptors. J Biol Chem 276:9924-9930. http://dx.doi.org/10.1074/jbc.M008610200.
52. Eto DS, Jones TA, Sundsbak JL, Mulvey MA. 2007. Integrin-mediated host cell invasion by type 1-piliated uropathogenic Escherichia coli. PLoS Pathog 3:e100. http://dx.doi.org/10.1371/journal.ppat.0030100.
53. Fowler T, Johansson S, Wary KK, HöökM. 2003. Src kinase has a central role in in vitro cellular internalization of Staphylococcus aureus. Cell Microbiol 5:417-426. http://dx.doi.org/10.1046/j.1462-5822.2003.00290.x.
54. Li K, Zhou W, Hong Y, Sacks SH, Sheerin NS. 2009. Synergy between type 1 fimbriae expression and C3 opsonisation increases internalisation of E. coli by human tubular epithelial cells. BMC Microbiol 9:64. http://dx.doi.org/10.1186/1471-2180-9-64.
55. Liu Z-B, Hou Y-F, Zhu J, Hu D-L, Jin W, Ou Z-L, Di G-H, Wu J, Shen Z-Z, Shao Z-M. 2010. Inhibition of EGFR pathway signaling and the metastatic potential of breast cancer cells by PA-MSHA mediated by type 1 fimbriae via a mannose-dependent manner. Oncogene 29:2996-3009. http://dx.doi.org/10.1038/onc.2010.70.
56. Wold AE, Mestecky J, Tomana M, Kobata A, Ohbayashi H, Endo T, Edén CS. 1990. Secretory immunoglobulin A carries oligosaccharide receptors for Escherichia coli type 1 fimbrial lectin. Infect Immun 58: 3073-3077.
57. Geerlings SE, Meiland R, van Lith EC, Brouwer EC, Gaastra W, Hoepelman AI. 2002. Adherence of type 1-fimbriated Escherichia coli to uroepithelial cells: more in diabetic women than in control subjects. Diabetes Care 25:1405-1409. http://dx.doi.org/10.2337/diacare.25.8.1405.
58. Issa S, Moran AP, Ustinov SN, Lin JH, Ligtenberg AJ, Karlsson NG. 2010. O-linked oligosaccharides from salivary agglutinin: Helicobacter pylori binding sialyl-Lewis x and Lewis b are terminating moieties on hyperfucosylated oligo-N-acetyllactosamine. Glycobiology 20:1046-1057. http://dx.doi.org/10.1093/glycob/cwq066.
59. Buts L, Bouckaert J, De Genst E, Loris R, Oscarson S, Lahmann M, Messens J, Brosens E, Wyns L, De Greve H. 2003. The fimbrial adhesin F17-G of enterotoxigenic Escherichia coli has an immunoglobulin-like lectin domain that binds N-acetylglucosamine. Mol Microbiol 49: 705-715. http://dx.doi.org/10.1046/j.1365-2958.2003.03600.x.
60. Hoffman MP, Haidaris CG. 1993. Analysis of Candida albicans adhesion to salivary mucin. Infect Immun 61:1940-1949.
61. de Repentigny L, Aumont F, Bernard K, Belhumeur P. 2000. Characterization of binding of Candida albicans to small intestinal mucin and its role in adherence to mucosal epithelial cells. Infect Immun 68:3172-3179. http://dx.doi.org/10.1128/IAI.68.6.3172-3179.2000.
62. Brockhausen I. 2006. Mucin-type O-glycans in human colon and breast cancer: glycodynamics and functions. EMBO Rep 7:599-604. http://dx.doi.org/10.1038/sj.embor.7400705.
63. Pilling D, Fan T, Huang D, Kaul B, Gomer RH. 2009. Identification of markers that distinguish monocyte-derived fibrocytes from monocytes, macrophages, and fibroblasts. PLoS One 4:e7475. http://dx.doi.org/10.1371/journal.pone.0007475.
64. Lefebvre JC, Giordanengo V, Limouse M, Doglio A, Cucchiarini M, Monpoux F, Mariani R, Peyron JF. 1994. Altered glycosylation of leukosialin, CD43, in HIV-1-infected cells of the CEM line. J Exp Med 180: 1609-1617. http://dx.doi.org/10.1084/jem.180.5.1609.
65. Lefebvre JC, Giordanengo V, Doglio A, Cagnon L, Breittmayer JP, Peyron JF, Lesimple J. 1994. Altered sialylation of CD45 in HIV-1-infected T lymphocytes. Virology 199:265-274. http://dx.doi.org/10.1006/viro.1994.1124.
66. Lantéri M, Giordanengo V, Hiraoka N, Fuzibet J-G, Auberger P, Fukuda M, Baum LG, Lefebvre J-C. 2003. Altered T cell surface glycosylation in HIV-1 infection results in increased susceptibility to galectin-1-induced cell death. Glycobiology 13:909-918. http://dx.doi.org/10.1093/glycob/cwg110.
67. Huynh KK, Eskelinen EL, Scott CC, Malevanets A, Saftig P, Grinstein S. 2007. LAMP proteins are required for fusion of lysosomes with phagosomes. EMBO J 26:313-324. http://dx.doi.org/10.1038/sj.emboj.7601511.
68. Kuhn DM, Vyas VK. 2012. The Candida glabrata adhesin Epa1p causes adhesion, phagocytosis, and cytokine secretion by innate immune cells. FEMS Yeast Res 12:398-414. http://dx.doi.org/10.1111/j.1567-1364.2011.00785.x.
69. Seider K, Brunke S, Schild L, Jablonowski N, Wilson D, Majer O, Barz D, Haas A, Kuchler K, Schaller M, Hube B. 2011. The facultative intracellular pathogen Candida glabrata subverts macrophage cytokine production and phagolysosome maturation. J Immunol 187:3072-3086. http://dx.doi.org/10.4049/jimmunol.1003730.
70. Ruhl S, Cisar JO, Sandberg AL. 2000. Identification of polymorphonuclear leukocyte and HL-60 cell receptors for adhesins of Streptococcus gordonii and Actinomyces naeslundii. Infect Immun 68:6346-6354. http://dx.doi.org/10.1128/IAI.68.11.6346-6354.2000.
71. Baba M, Yong Ma B, Nonaka M, Matsuishi Y, Hirano M, Nakamura N, Kawasaki N, Kawasaki N, Kawasaki T. 2007. Glycosylation-dependent interaction of jacalin with CD45 induces T lymphocyte activation and Th1/Th2 cytokine secretion. J Leukoc Biol 81:1002-1011. http://dx.doi.org/10.1189/jlb.1106660.
72. Knight SA, Vilaire G, Lesuisse E, Dancis A. 2005. Iron acquisition from transferrin by Candida albicans depends on the reductive pathway. Infect Immun 73:5482-5492. http://dx.doi.org/10.1128/IAI.73.9.5482-5492.2005.
73. Almeida RS, Brunke S, Albrecht A, Thewes S, Laue M, Edwards JE, Filler SG, Hube B. 2008. The hyphal-associated adhesin and invasin Als3 of Candida albicans mediates iron acquisition from host ferritin. PLoS Pathog 4:e1000217. http://dx.doi.org/10.1371/journal.ppat.1000217.
74. Petrou MA, Rogers TR. 1988. The inhibitory effect of serum on the growth of torulopsis glabrata. J Med Microbiol 25:213-220. http://dx.doi.org/10.1099/00222615-25-3-213.
75. Naidu AS, Chen J, Martinez C, Tulpinski J, Pal BK, Fowler RS. 2004. Activated lactoferrin’s ability to inhibit Candida growth and block yeast adhesion to the vaginal epithelial monolayer. J Reprod Med 49:859-866.
76. Zhu W, Phan QT, Boontheung P, Solis NV, Loo JA, Filler SG. 2012. EGFR and HER2 receptor kinase signaling mediate epithelial cell invasion by Candida albicans during oropharyngeal infection. Proc Natl Acad SciU S A 109:14194-14199. http://dx.doi.org/10.1073/pnas.1117676109.
77. Phan QT, Myers CL, Fu Y, Sheppard DC, Yeaman MR, Welch WH, Ibrahim AS, Edwards JE, Jr., Filler SG. 2007. Als3 is a Candida albicans invasin that binds to cadherins and induces endocytosis by host cells. PLoS Biol 5:e64. http://dx.doi.org/10.1371/journal.pbio.0050064.
78. Salgado PS, Yan R, Taylor JD, Burchell L, Jones R, Hoyer LL, Matthews SJ, Simpson PJ, Cota E. 2011. Structural basis for the broad specificity to host-cell ligands by the pathogenic fungus Candida albicans. Proc Natl Acad Sci U S A 108:15775-15779. http://dx.doi.org/10.1073/pnas.1103496108.
79. McFadden K, Cocklin S, Gopi H, Baxter S, Ajith S, Mahmood N, Shattock R, Chaiken I. 2007. A recombinant allosteric lectin antagonist of HIV-1 envelope gp120 interactions. Proteins 67:617-629. http://dx.doi.org/10.1002/prot.21295.
80. Hoorelbeke B, Huskens D, Férir G, François KO, Takahashi A, Van Laethem K, Schols D, Tanaka H, Balzarini J. 2010. Actinohivin, a broadly neutralizing prokaryotic lectin, inhibits HIV-1 infection by specifically targeting high-mannose-type glycans on the gp120 envelope. Antimicrob Agents Chemother 54:3287-3301. http://dx.doi.org/10.1128/AAC.00254-10.
81. Kase T, Suzuki Y, Kawai T, Sakamoto T, Ohtani K, Eda S, Maeda A, Okuno Y, Kurimura T, Wakamiya N. 1999. Human mannan-binding lectin inhibits the infection of influenza A virus without complement. Immunology 97:385-392. http://dx.doi.org/10.1046/j.1365-2567.1999.00781.x.
82. Kawai T, Kase T, Suzuki Y, Eda S, Sakamoto T, Ohtani K, Wakamiya N. 2007. Anti-influenza A virus activities of mannan-binding lectins and bovine conglutinin. J Vet Med Sci 69:221-224. http://dx.doi.org/10.1292/jvms.69.221.
83. Ji X, Olinger GG, Aris S, Chen Y, Gewurz H, Spear GT. 2005. Mannosebinding lectin binds to Ebola and Marburg envelope glycoproteins, resulting in blocking of virus interaction with DC-SIGN and complementmediated virus neutralization. J Gen Virol 86:2535-2542. http://dx.doi.org/10.1099/vir.0.81199-0.
84. Smee DF, Bailey KW, Wong MH, O’Keefe BR, Gustafson KR, Mishin VP, Gubareva LV. 2008. Treatment of influenza A (H1N1) virus infections in mice and ferrets with cyanovirin-N. Antiviral Res 80:266-271. http://dx.doi.org/10.1016/j.antiviral.2008.06.003.
85. Diderrich R, Kock M, Maestre-Reyna M, Keller P, Steuber H, Rupp S, Essen L-O, Mösch H-U. 2015. Structural hotspots determine functional diversity of the Candida glabrata epithelial adhesin family. J Biol Chem 290:19597-19613. http://dx.doi.org/10.1074/jbc.M115.655654.
86. Bastian M, Heymann S, Jacomy M. 2009. Gephi: an open source software for exploring and manipulating networks. Proc Third Int ICWSM Conf. https://gephi.org/publications/gephi-bastian-feb09.pdf.
87. Brandes U, Pich C. 2009. An experimental study on distance-based graph drawing, p 218-229. In Tollis G, Patrignani M, Pich C (ed), Graph drawing. Lecture notes in computer science. Springer-Verlag, Berlin, Germany.
88. Smoot ME, Ono K, Ruscheinski J, Wang PL, Ideker T. 2011. Cytoscape 2.8: new features for data integration and network visualization. Bioinformatics 27:431-432. http://dx.doi.org/10.1093/bioinformatics/btq675.
89. Barsky A, Gardy JL, Hancock RE, Munzner T. 2007. Cerebral: a cytoscape plugin for layout of and interaction with biological networks using subcellular localization annotation. Bioinformatics 23:1040-1042. http://dx.doi.org/10.1093/bioinformatics/btm057.
90. Vermeire K, Princen K, Hatse S, De Clercq E, Dey K, Bell TW, Schols D. 2004. Cada, a novel CD4-targeted HIV inhibitor, is synergistic with various anti-HIV drugs in vitro. AIDS 18:2115-2125. http://dx.doi.org/10.1097/00002030-200411050-00003.
91. Wasserman S, Faust K. 1994. Social network analysis: methods and applications, p. Cambridge University Books, New York, NY.
92. Bonacich P. 1987. Power and centrality: a family of measures. Am J Sociol 92:1170-1182. http://dx.doi.org/10.1086/228631.
93. Katz L. 1953. A new status index derived from sociometric analysis. Psychometrika 18:39-43. http://dx.doi.org/10.1007/BF02289026.